The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

Share Price Information for K3 Business Technology Group (KBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.941%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
KBT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Jan 2023 07:00

RNS Number : 4488M
K3 Business Technology Group PLC
12 January 2023
 

 

AIM: KBT

12 January 2023

K3 BUSINESS TECHNOLOGY GROUP PLC

("K3" or "the Group" or "the Company")

 

Provider of business-critical software solutions focused on fashion and apparel brands.

 

Trading Update

 

K3, which provides business‐critical software solutions focused on fashion and apparel brands, is pleased to announce an update on trading for the financial year ended 30 November 2022.

 

The Group continued to make very encouraging progress against its strategic plan and K3's second half performance is in line with management expectations.

 

Group revenue for the year is expected to be ahead of last year, with recurring and predictable revenue also higher. A key measure is the total annualised recurring contract value of software licences from Strategic Products, and this has made a significantly higher contribution year-on-year; we looking forward to giving more detail at the time of the final results release. This rise reflects existing customers expanding the number of their product licences as well as new customer wins.

 

Adjusted EBITDA for the financial year FY 2022 is expected to be no less than £5.0m (2021: £4.4m). The net cash position is expected to close at c. £7.1m (2021: £9.0m). Cash flows in the second half benefited from a 98% renewal rate of product licence and maintenance and support renewals (2021: 98%).

 

The new financial year has started well, especially for Strategic Products, with both new logos customers and expansion, and cash generation is trending higher year-on-year.

 

Final results for FY 2022 are expected to be published towards the end of March 2023.

 

 

Enquiries:

 

K3 Business Technology Group plc

Marco Vergani, Chief Executive Officer

www.k3btg.com

Robert Price, Chief Financial Officer

T: 0161 876 4498

 

finnCap Limited

(NOMAD & Broker)

Julian Blunt (Corporate Finance)

Sunila De Silva (Corporate Broking)

T: 020 7220 0500

KTZ Communications

Katie Tzouliadis/ Dan Maloney

T: 020 3178 6378

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFFWFEDSEEF
Date   Source Headline
26th Apr 20247:00 amRNSPosting of Annual Report and Notice of AGM
8th Apr 202410:50 amRNSPDMR Announcement
2nd Apr 20244:00 pmRNSPDMR Announcement
26th Mar 20247:00 amRNSFinal Results
29th Jan 20241:00 pmRNSPDMR Announcement
15th Jan 202410:00 amRNSPDMR Announcement
20th Dec 20237:00 amRNSTrading Update
19th Dec 20238:52 amRNSPDMR Announcement
21st Nov 20237:00 amRNSPDMR Announcement
30th Oct 20237:00 amRNSBoard Changes
30th Aug 20237:00 amRNSInterim Results
21st Jul 20235:50 pmRNSPDMR Announcement
7th Jul 20235:10 pmRNSPDMR Announcement
30th Jun 20235:15 pmRNSPDMR Announcement
23rd Jun 20236:00 pmRNSPDMR Announcement
19th Jun 20237:00 amRNSPDMR Announcement
30th May 20231:30 pmRNSPDMR Announcement
23rd May 202311:15 amRNSResult of AGM
19th May 20235:52 pmRNSHolding(s) in Company
19th May 20235:45 pmRNSPDMR Announcement
19th May 20232:45 pmRNSHolding(s) in Company
18th May 202312:58 pmRNSHolding(s) in Company
18th May 202312:45 pmRNSHolding(s) in Company
18th May 202312:40 pmRNSPDMR Announcement
9th May 20237:28 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
2nd May 20239:35 amRNSPDMR Announcement
28th Apr 20234:07 pmRNSPosting of Annual Report and Notice of AGM
12th Apr 202312:57 pmRNSDirector/PDMR Shareholding
3rd Apr 20231:30 pmRNSPDMR Announcement
30th Mar 20237:00 amRNSFinal Results
30th Mar 20237:00 amRNSBoard Appointment
7th Mar 20237:00 amRNSLargest Order Win for Flagship Fashion Product
6th Feb 202310:00 amRNSPDMR Announcement
23rd Jan 202311:10 amRNSPDMR Announcement
12th Jan 20237:00 amRNSTrading Update
28th Nov 20225:07 pmRNSHolding(s) in Company
28th Nov 20225:05 pmRNSPDMR Announcement
21st Nov 20225:40 pmRNSPDMR Announcement
14th Nov 202212:50 pmRNSPDMR Announcement
7th Nov 20223:53 pmRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
17th Oct 202210:46 amRNSPDMR Announcement
20th Sep 20224:45 pmRNSPDMR Announcement
12th Sep 20225:31 pmRNSPDMR Announcement
24th Aug 20227:00 amRNSInterim Results
26th Jul 20227:00 amRNSBoard Appointment
19th May 202210:57 amRNSResult of AGM
18th May 20225:27 pmRNSK3 LTIP Option Scheme
16th May 202210:42 amRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.